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Background: The Syrian golden hamster (Mesocricetus aureus) has been used as a model to study infections caused
by a number of human pathogens. Studies of immunopathogenesis in hamster infection models are challenging
because of the limited availability of reagents needed to define cellular and molecular determinants.
Results: We sequenced a hamster cDNA library and developed a first-generation custom cDNA microarray that
included 5131 unique cDNAs enriched for immune response genes. We used this microarray to interrogate the
hamster spleen response to Leishmania donovani, an intracellular protozoan that causes visceral leishmaniasis. The
hamster model of visceral leishmaniasis is of particular interest because it recapitulates clinical and immunopathological
features of human disease, including cachexia, massive splenomegaly, pancytopenia, immunosuppression, and
ultimately death. In the microarray a differentially expressed transcript was identified as having at least a 2-fold change
in expression between uninfected and infected groups and a False Discovery Rate of <5%. Following a relatively silent
early phase of infection (at 7 and 14 days post-infection only 8 and 24 genes, respectively, were differentially expressed),
there was dramatic upregulation of inflammatory and immune-related genes in the spleen (708 differentially expressed
genes were evident at 28 days post-infection). The differentially expressed transcripts included genes involved in
inflammation, immunity, and immune cell trafficking. Of particular interest there was concomitant upregulation of the
IFN-γ and interleukin (IL)-4 signaling pathways, with increased expression of a battery of IFN-γ- and IL-4-responsive
genes. The latter included genes characteristic of alternatively activated macrophages.
Conclusions: Transcriptional profiling was accomplished in the Syrian golden hamster, for which a fully annotated
genome is not available. In the hamster model of visceral leishmaniasis, a robust and functional IFN-γ response did not
restrain parasite load and progression of disease. This supports the accumulating evidence that macrophages are
ineffectively activated to kill the parasite. The concomitant expression of IL-4/IL-13 and their downstream target genes,
some of which were characteristic of alternative macrophage activation, are likely to contribute to this. Further
dissection of mechanisms that lead to polarization of macrophages toward a permissive state is needed to fully
understand the pathogenesis of visceral leishmaniasis.
Keywords: Hamster, Leishmania donovani, Visceral leishmaniasis, Transcriptional profiling, Microarray, Interferon-gamma,
Interleukin-4* Correspondence: pcmelby@utmb.edu
2Department of Internal Medicine, University of Texas Medical Branch,
Galveston, Texas, USA
3Department of Microbiology and Immunology, University of Texas Medical
Branch, Galveston, Texas, USA
Full list of author information is available at the end of the article
© 2014 Espitia et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Espitia et al. BMC Immunology 2014, 15:38 Page 2 of 14
http://www.biomedcentral.com/1471-2172/15/38Background
The Syrian golden hamster (Mesocricetus aureus) is sus-
ceptible to, and has been used as a model for, a number
of human pathogens, including Leishmania (Viannia)
spp. [1-4], L. donovani [5,6], Trypanosoma cruzi [7], Ent-
amoeba histolytica [8], Leptospira and Treponema [9,10],
hantavirus [11], Eastern equine encephalitis virus [12],
Yellow Fever virus [13,14], West Nile virus [15], Nipah
virus [16], and hookworm [17]. In some cases, hamster
models of infection provide a unique opportunity to
determine mechanisms of disease and immunity because
the human infection is more closely mimicked in this
animal than in other animal models. Studies of immuno-
pathogenesis in hamster infection models are challenging,
however, because of the limited availability of reagents
needed to define cellular and molecular determinants. For
the most part, antibodies directed against mouse and rat
proteins do not cross-react with the hamster orthologs,
and the lack of a fully annotated genome sequence limits
broad interrogation of the genome and transcriptome.
The leishmaniases are a diverse group of diseases caused
by intracellular protozoan parasites of the genus
Leishmania. Visceral leishmaniasis (VL) is one of the
“Neglected Tropical Diseases” that impacts the most
resource-poor regions of the world. Active VL, caused by
L. donovani, is characterized by a progressive increase in
visceral parasite burden, cachexia, massive splenomegaly,
pancytopenia and ultimately death. There are significant
gaps in our understanding of the molecular and cellular
determinants underlying the pathogenesis of VL. The
Syrian hamster (Mesocricetus auratus) affords a unique
opportunity to address these gaps because the clinicopath-
ological features of VL in the hamster closely mimic active
human disease. In recent reports [5,18] we demonstrated
that despite mounting a vigorous Type 1 cellular immune
response, an immunological event that is associated with
control of infection in mice, the hamster develops a
progressive, lethal disease. This paradoxical finding was
reminiscent of the findings in humans [19,20]. Further-
more, we found that the inability of L. donovani infected
hamsters to control parasite replication was related to in-
effective IFN-γ-mediated classical macrophage activation,
evident by reduced expression of inducible nitric oxide
synthase (NOS2) and production of nitric oxide (NO),
which is the primary mechanism by which mice control
Leishmania infection [5,18]. We found that parasitized
macrophages were not deactivated but showed a M2
(“alternatively activated”) phenotype where the expression
of host arginase 1 (arg1) dominated at the site of infection
[21,22]. Although it is a well-established paradigm that
M2 macrophages are driven by Th2 cytokines, we disco-
vered that L. donovani infection of macrophages and
fibroblasts induced the expression of arg1 through an
IL-4-independent, but STAT6 dependent, mechanism[21,22]. Furthermore, the activation of STAT6 and expres-
sion of arg1 enhanced intracellular parasite replication
[21,22]. To better define the splenic environment that
leads to a failure of host defense, we investigated the
splenic response to L. donovani infection in the hamster
model of progressive VL by use of a custom cDNA micro-
array. We show that following a relatively silent early
phase of infection there is dramatic upregulation of
inflammatory and immune-related genes in the spleen that
is coincident with the exponential increase in parasite rep-
lication [21,22]. The gene expression profiling identified a
mixed cytokine response of IFN-γ, IL-4 and IL-10 with
corresponding expression of a large number of cytokine-
responsive genes in VL.
Results and discussion
Hamster cDNA sequence assembly, characterization, and
annotation
As noted above there are a number of experimental
infection models in Syrian hamsters that are relevant to
human disease [1-17]. However, there is limited avai-
lability of molecular tools for studies of disease patho-
genesis in this model. A draft genome of Mesocricetus
auratus determined via genome shotgun sequencing has
been reported (NCBI Accession APMT01000001), but it
was incompletely annotated at the time when the data
presented here were being analyzed. As an initial ap-
proach to address this obstacle we sequenced a Syrian
hamster cDNA library constructed from a pool of
mRNA that had been isolated from 1) spleen, LN cells,
and peritoneal macrophages exposed to various stimuli,
and 2) normal tissue or tissue harvested from hamsters
infected in vivo with several different pathogens. We
chose to use cells and tissues that had been exposed to a
broad range of stimuli and pathogens (bacteria, viruses,
protozoa, and helminths) in order to enrich for a diverse
set of mRNAs involved in immune responses. From
the cDNA library 10,000 independent clones were se-
quenced to obtain 5085 unique expressed sequence tags
(EST). Datasets representing all sequences were assembled
into contigs of overlapping sequences using Phred (for ac-
curate base-calling from DNA sequence traces) and Phrap
(for fast and accurate DNA sequence assembly), and were
compared to the non-redundant nucleotide database using
the BLAST algorithm [23]. Sequences that had a signifi-
cant match with a mouse, rat, or human sequence were
considered Syrian hamster orthologs of the closest match.
The breakdown of closest match by non-hamster species
is shown in Additional file 1: Table S1. Hamster cDNAs
had the highest level of homology with mouse (49.6%) and
rat (27.7%) sequences; 12.9% did not have a significant
match to the GenBank database. Only 4.5% of sequences
showed the highest homology to human or non-human
primate DNA and 3.7% of sequences matched to
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gin since RNA from the protozoa, helminthes, or viruses
in the infected tissue would have been included in the
RNA used to construct the library (see Additional file 1:
Table S1).
Analysis of splenic gene expression by microarray
The immunopathogenic mechanisms that contribute to
visceral leishmaniasis (VL) are not clearly understood.
In a model of progressive VL [5,6,18,21,22] we investi-
gated splenic gene expression over the course of infec-
tion using a first generation cDNA custom microarray.
5085 unique ESTs from the cDNA library, and an add-
itional 46 cDNAs that we had cloned independently
(references [5,6,18,22,24], and Melby, unpublished)
were amplified and spotted in duplicate onto a micro-
array making a total of 5131 unique cDNAs plus
replicates of several housekeeping genes. We used the
microarray to define the expression of splenic mRNAs
in response to visceral L. donovani infection at 7, 14,
and 28 days post-infection.
Using Partek GS, a Principal Component Analysis
(PCA) was performed to identify major effects influen-
cing the expression values at each time point [25]. This
is an exploratory global data analysis of the genome and
not an analysis of any gene in particular. It was used for
quality control of the data on all the samples (Figure 1).
In general, samples that map closely are similar across
the whole genome, whereas samples that map distantly
are dissimilar across the whole genome [26]. A distinct
clustering between uninfected and infected groups was
clearly identified, showing that the infection status, and
not a batch effect due to Cy5 or Cy3 labelling or the file
(representing a couple of infected and uninfected ham-
sters/spleen tissues) had the largest effect on the data at
all time points. Also no outliers were identified; dye-
swap arrays (files 11 and 12 for each time point) from
pooled samples clustered within the correspondent
infection status (Figure 1). Thus, infection status had the
major impact on differential gene expression in the
spleens.
After curation of the differentially expressed EST, the
lists were reduced to identifiable differentially expressed
hamster genes. We demonstrated previously that in the
hamster model of VL there is an initial period of silent
infection, with little activation of the immune response,
followed by a sharp increase in spleen size, number of
macrophages, and splenic parasite burden [5,21,22]. The
gene expression data presented here corroborated this
previous observation at a much broader transcriptomic
level (Table 1), but it must be recognized that minor
changes in gene expression may not be detected by
microarray. When ESTs that had at least a 2-fold change
in the mean expression between the uninfected andinfected groups (n = 5 per group) and a False Discovery
Rate (FDR) of <5% were considered to be differentially
expressed, 8 and 24 genes were differentially expressed at
7 and 14 days post-infection, respectively, but 708 genes
were differentially expressed at 28 days post-infection
(Table 1 and Additional file 2: Table S2, Additional file 3:
Table S3 and Additional file 4: Table S4). At this latter
time point we demonstrated previously that there was a
dramatic increase in parasite burden and accumulation of
cells, especially macrophages, in the spleen [21,22]. When
at least a 2-fold change and a p value <0.05 was used as
the threshold for significance the number of differentially
expressed genes was higher. In the analysis of the data
presented here we used a >2-fold change and FDR <5% to
define the set of differentially expressed genes.
As shown in the volcano plots in Figure 1, most genes
in the infected groups were expressed at less than a
2.0-fold increase or decrease over the age-matched
uninfected control group. However, at each of the time
points there was cluster of highly upregulated mRNAs,
which increased over the course of infection such that at
28-days post-infection there were 165 mRNAs with a
fold-increase of >20 (Figure 1; Additional file 5: Table
S5). Only a small number mRNAs (n = 27) were down-
regulated at 28-days post-infection. This is contrary to
the previously held view, derived from microarray data
from in vitro infected mouse [27,28] and human [29]
macrophages, that Leishmania infection had a broadly
silent or suppressive rather than stimulatory effect on
host transcription. However, these studies would not
have included the multiple different cell populations and
a myriad of inflammatory signals present in the whole
infected spleen tissue. It should also be noted that the
cDNA library from which the microarray was created in-
cluded RNA isolated from Leishmania-infected hamsters
so it is likely that the microarray was enriched for genes
that were upregulated in that infection model. The num-
ber of down-regulated genes was therefore probably
underestimated. Comparable transcriptome profiling has
not been reported for the spleens of L. donovani infected
mice or humans.
As noted earlier, Leishmania DNA may have been in-
cluded in the microarray and/or Leishmania RNA could
have cross-hybridized with an orthologous hamster EST.
To minimize the possibility that Leishmania orthologs
could confound the interpretation of the data, differen-
tially expressed genes were ignored if the EST was obvi-
ously derived from a pathogen (including Leishmania).
The possibility of a Leishmania RNA cross-hybridizing
to the hamster ortholog (giving a false impression that
the hamster transcript was upregulated) cannot be ex-
cluded. For some ESTs assigning a gene symbol was
challenging. A case in point is Bbs1, in which there is a
Leishmania ortholog of the mammalian gene [30]. This
Figure 1 Principle Component Analysis and Volcano Plots of transcripts expressed in the spleens of uninfected or infected hamsters.
A, C, E. Principle Component Analysis of uninfected and infected spleen tissue at 7 days (A), 14 days (C), and 28 days (E) post-infection. The
groups of uninfected samples are circled in blue and infected samples are circled in red. The Cy3 and Cy5 dyes are represented by green and red
symbols, respectively. Dye-swap arrays (files 11 and 12 for each time point) from pooled samples clustered appropriately within the corresponding
infection status. B, D, F. Volcano plots showing the mean fold-change and p-value for the comparisons of uninfected and infected spleen tissue
at 7 days (B), 14 days (D) and 28 days (F) post-infection. Red triangles show a fold-change >1 and blue triangles show a fold-change <1.
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Table 1 Differentially expressed EST in the hamster




Number of differentially expressed
EST (Infected vs Uninfected)




*FC = fold change; FDR = false discovery rate.
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in the 28-day infected hamster spleen (Additional file 4:
Table S4). It showed homology to the 3′ end of the
mouse Bbs1 sequence (therefore was labeled as Bbs1),
but did not have sequence homology to the incompletely
annotated hamster (Mesocricetus auratus) genome or to
the published Leishmania sequence. Using qRT-PCR
and specific primers there was no increase in the tran-
script of the published hamster Bbs1 but a substantial
increase in the Leishmania Bbs1 ortholog (data not
shown). Therefore, the Leishmania Bbs1 ortholog was
highly expressed in the spleen during infection, the EST
labeled as Bbs1 based on homology to the mouse se-
quence was upregulated, but this differentially expressed
gene was not identical to the published hamster Bbs1
sequence. Other similar examples may exist, but these
would primarily concern housekeeping/metabolic genes
so would not affect the interpretation of the immuno-
logical findings of this study.
Hierarchical clustering using Euclidean distance and
average linkage was applied to the differentially expressed
genes at 28 days post-infection. The Heatmap and dendro-
gram of the samples showed a pattern consistent with the
PCA, where arrays grouped under two major categories
regardless of the labeling dye (Figure 2). The clustering of
genes based on the similarity of their expression patterns
suggests, but does not prove, that they have a similar bio-
logical function [31]. In general, all genes clustered into
two expression groups, infected and uninfected. Because
of the high number (708) of differentially expressed genes
at 28-day infection, a gene ontology (GO)-enrichment
analysis [32] using Partek GS was made to better under-
stand their putative biological function (Table 2). High en-
richment scores were detected for a number of biological
functions that involved immune and inflammatory re-
sponses. This was not unexpected, since the cDNA library
was designed to be enriched for immune-related genes.
Identification of the genes included in the immune
response and inflammatory response functions and their
fold-increase is shown in Table 3.
Analysis of the differentially expressed genes by the
“WEB-based GEne SeT AnaLysis Toolkit” [33,34] and
WikiPathways [35] revealed a number of pathways thatwere significantly upregulated by infection (Table 4).
These analyses were no doubt limited by the incomplete
representation of the hamster transcriptome in the cus-
tom microarray. Nevertheless, the transcripts that were
differentially regulated at day-28 p.i. represented a broad
array of genes involved in inflammation, immunity,
immune cell trafficking, and metabolism. Of particular
interest were the pathways involved in T cell subset
polarization and effector function. The Enrichment Ratio
(ER; ratio of differentially expressed genes in the gene
set to the expected number in the pathway published for
mice) was significantly increased for the Type II inter-
feron (IFN-γ) (ER = 17.77; p = 1.18e-11) and IL-4 signal-
ing pathways (ER = 12.14, 6.89e-07) in the infected
animals. Because the custom microarray did not likely
include all members of a pathway the numerator of the
ER is probably artificially low. The denominator is set
independent of the microarray (based on publications
related to the pathway in mice), so the calculated En-
richment Ratio is likely to be an underestimate of the
true significance.
IFN-γ potently conveys antimicrobial properties to
macrophages by inducing the transcription of a broad
repertoire of genes [36]. In murine models of Leish-
mania infection, IFN-γ, produced primarily by CD4+
and CD8+ T cells, is critical to the control of infection
(reviewed in [37]). Paradoxically, in the hamster model
of progressive VL [5,18], as well as in humans with ac-
tive VL [19,20,38], there are high levels of IFN-γ expres-
sion without effective control of infection. Indeed, in the
microarray analysis, IFN-γ was the second most highly
differentially expressed transcript (>1700-fold increase)
at 28-days post-infection (Table 3; Additional file 5:
Table S5), a time point in the course of infection when
there is a massive increase in splenic parasite burden
[21,22]. The reason(s) why IFN-γ (and its downstream tar-
gets) effectively controls the parasite burden over time in
mice but not in hamsters is not fully understood. Further-
more, we found evidence of upregulation of a number
of known interferon-responsive genes (Figure 3A). In
independent experiments we verified the microarray re-
sults by confirming the increased expression of a subset of
these IFN-induced transcripts (indoleamine dioxygenase-1
[Ido1], immune-responsive gene 1 [Irg1], CXC chemokine
ligand 9 [Cxcl9], Cxcl10, and interferon regulatory factor-1
[Irf1]) in the spleens of 28-day infected hamsters by qRT-
PCR (Figure 3B). Notably, and consistent with our previ-
ous work, we found minimal increase in inducible nitric
oxide synthase 2 (Nos2) expression, which is the primary
effector mechanism for macrophage-mediated killing of
intracellular Leishmania in mice [39,40]. We previously
identified sequences in the hamster NOS2 promoter that
rendered it less responsive to classical activating stimuli
[41]. However, the transcriptional profiling presented here
Figure 2 Hierarchical Clustering of differentially expressed transcripts in the spleens of hamsters infected with L. donovani for 28 days.
Unsupervised hierarchical clustering of differentially expressed genes (>2-fold change and FDR <5%) in the spleens of uninfected (UN) and 28-day
infected (INF) hamsters. The heatmap is color-coded using red for up-regulated genes and blue for down-regulated genes.
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suppressed in macrophages. The high level of expression
of the transcription factor IRF2 (Table 3; Figure 3A),
which is synergistically induced by IFN-γ and IL-4 [42],
may compete with IRF-1 to repress the transactivation of
Nos2 and other IFN-inducible genes [42,43]. This possible
mechanism of impaired Nos2 expression remains to be
explored.
The potential roles of other IFN-γ-responsive genes in
the defense against Leishmania are incompletely under-
stood. The expression of indoleamine 2,3-dioxygenase-1
(Ido1) and tryptophan 2,3-dioxygenase (Tdo), which can
limit pathogen replication by local depletion of trypto-
phan [44-46], was significantly increased in the spleens
of infected animals (Additional file 4: Table S4; Figure 3A
and 3B). However, consistent with our results, recent
work determined that the expression of Ido1 may sup-
press both innate and adaptive anti-leishmanial immune
responses [47,48] and Ido-1 is a marker of diseaseTable 2 Classification of differentially expressed genes by gen
infection
Function Type
Extracellular space Cellular component
Immune response Biological process
Inflammatory response Biological process
Extracellular region Cellular component
Chemokine activity Molecular function
Platelet degranulation Biological process
Chemotaxis Biological process
Blood coagulation Biological process
1Gene ontology (GO)-enrichment analysis using Partek GS.
2Ratio of the number of genes in the gene set to the expected number in the categ
3p value adjusted by the multiple test adjustment.activity in human VL [49]. The expression of Cxcl9 and
Cxcl10, which signal through the Cxcr3 receptor, was
greatly increased in the spleens of hamsters with VL
(35- and 12-fold, respectively) (Table 3; Figure 3A and
3B; Additional file 4: Table S4) and they were elevated in
the serum of patients with VL [50]. Their role in defense
against VL is uncertain. In L. major infected mice Cxcr3
was required for resolution of infection through recruit-
ment of effector T cells to the site of infection [51]. In L.
donovani infected mice, however, Cxcr3 was not re-
quired for development of a Th1 response and control of
hepatic infection [52]. A number of transcripts from the
family of IFN-inducible GTPases (Igtp, Iigp1b, Irgm2,
Tgtp1, Tgtp2, Gbp2, Gbp5) were increased in the spleen
of hamsters with VL (Figure 3A; Additional file 4: Table S4).
This family of proteins includes the immunity-related
GTPases (p47 IRGs) and p65 guanylate binding proteins
(p65 GBPs) that promote resistance against intracellular
bacterial, viral and protozoal pathogens (reviewed in [53]).e ontology1 in the hamster spleen after 28 days of









ory based on the human database.
Table 3 Genes included in the “Immune Response” and
“Inflammatory Response” Gene Ontology functions from
differentially expressed genes after 28 days of infection










Ifng 1748.95 9.71E-05 Ccl11 1212.26 0.00035
Ccl11 1212.26 0.00035 Ccl20 749.90 0.00133
Ccl20 749.90 0.00134 Cxcl1 488.25 4.04E-05
Igha1 653.51 8.07E-06 Reg3g 348.91 6.26E-05
Cxcl5 653.22 1.28E-04 Chst4 197.33 3.52E-05
Csf3 509.58 8.54E-06 Cdo1 45.39 0.0001
Cxcl1 488.25 4.04E-05 Cxcl9 35.64 7.46E-06
Azgp1 234.93 2.52E-05 Ccl17 16.36 0.020
Chst4 197.33 3.52E-05 Ccr5 13.75 3.60E-05
Cxcl9 35.64 7.46E-06 Cxcl10 12.16 2.25E-05
Ccl17 16.36 0.020 Fpr2 10.12 0.00073
Il21 14.64 6.74E-04 Il1rn 9.50 0.00026
Ccr5 13.75 3.60E-05 Hrh1 8.74 0.005
Cxcl10 12.16 2.25E-05 Aoah 6.33 0.00011
Gbp2 9.86 1.45E-05 Kng1 5.25 0.012
Cst7 9.53 0.00038 C5 5.17 0.022
Il1rn 9.50 0.00026 Cybb 4.97 0.00011
IL4 9.18 2.62E-05 IL10 4.57 0.00092
IL2Ra 8.15 0.0009 Mif 4.55 0.0117
Cd8a 6.73 0.0185 IL6 4.50 0.00059
Oasl 6.12 1.12E-04 Ccl22 3.68 0.00092
IL2 4.75 0.0122 Cxcl2 3.44 0.00723
Gzma 4.28 4.24E-04 Cxcl3 3.38 0.00965
Igsf6 4.15 0.0121 Lipa 3.02 8.24E-05
Il12a 4.14 0.0185 C3 2.96 2.79E-05
Ctss 3.88 0.0021 Slc11a1 2.72 1.04E-05
Igha1 3.79 4.57E-05 Tirap 2.28 0.00035













Table 3 Genes included in the “Immune Response” and
“Inflammatory Response” Gene Ontology functions from








Espitia et al. BMC Immunology 2014, 15:38 Page 7 of 14
http://www.biomedcentral.com/1471-2172/15/38Targeted disruption of some, but not all, of these genes in
mice enhanced susceptibility to dermatropic Leishmania
strains [54] but the role of this family in L. donovani infec-
tion is unknown. Our data indicate that their expression
does not preclude the progression of VL. Collectively,
these data reinforce the notion that progressive VL is not
driven by the absence of IFN-γ production or a global
deficit in IFN-γ responsiveness, but that other factors lead
to unresponsive macrophage effector function.
The type 2 cytokines, interleukin (IL)-4 and IL-13, are
likely to contribute to the pathogenesis of experimental
VL. IL-4 expression was increased 9.2-fold in the spleens
of 28-day infected compared to uninfected hamsters
(Table 3; Figure 4A; Additional file 4: Table S4), confirm-
ing our previous findings [5,6,22]. IL-13 was increased
8.2-fold, however, it did not meet the FDR criteria for a
differentially expressed gene. By quantitative RT-PCR we
recently determined that its expression was increased in
the spleen of hamsters with VL [22]. IL-4 and IL-13
signal through pathways that have considerable overlap:
the IL-4 and IL-13 receptors share the IL-4Rα chain and






Amino Acid Metabolism 16.26 7.79e-15
Complement and Coagulation Cascades 21.56 1.66e-12
Adipogenesis 12.17 1.18e-11
Type II interferon signaling (IFN-γ) 17.77 1.18e-11
Chemokine signaling pathway 9.25 1.46e-10
Blood clotting cascade 39.54 2.74e-10




IL-4 signaling pathway 12.14 6.89e-07
IL-2 Signaling pathway 9.90 3.38e-06
1Ratio of the number of genes in the gene set to the expected number in the
category based on the human database.
2p value adjusted by the multiple test adjustment.
Figure 3 Upregulation of Interferon-γ-inducible genes in the spleens of 28-day infected hamsters. (A) Schematic representation of the
IFN-γ pathway with notation of interferon-γ-inducible genes found by microarray to be upregulated in the spleens of hamsters at 28 days post-infection.
The fold-increase of the mRNA in the infected tissue is shown in blue in parentheses. (B) Expression of interferon-γ-inducible genes in the spleens of
28-day infected hamsters determined by real time RT-PCR. Data are shown as the mean and standard error of the mean (error bars) of the fold-increase in
infected compared to uninfected animals (n = 5 per group). ***p≤ 0.001.
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IL-4, and to a lesser extent IL-13, plays a prominent role
in the immunopathogenesis of murine L. major infection
(reviewed in [55]). However, in mice infected with L.
donovani, where parasite replication is ultimately con-
trolled and the animals do not develop progressive
disease, IL-4 and IL-13 do not contribute to host
susceptibility [56,57]. In fact, IL-13 promotes the forma-
tion of hepatic granulomas and control of murine L.
donovani infection [58]. The significance of IL-4 and IL-13 in human VL has not been fully addressed. IL-4 is
increased in the spleens [59] and IL4 and IL-13 are
increased in the plasma or serum [59-61] of patients
with active VL. Our previous work in the hamster model
of progressive VL identified STAT6-dependent, IL-4-
amplifying M2-like macrophage polarization as a critical
determinant of progressive disease [22]. The microarray
data presented here revealed that a number of IL-4/IL-
13-responsive genes were upregulated during infection
(Figure 4A; Additional file 4: Table S4), including genes
Figure 4 Upregulation of IL-4/13-inducible genes in the spleens of 28-day infected hamsters. (A) Schematic representation of the IL-4 and
IL-13 signaling pathways with notation of IL-4/IL-13-responsive genes found by microarray to be upregulated in the spleens of hamsters at 28 days
post-infection. The fold-increase of the gene in the infected tissue is shown in blue in parentheses. (B) Expression of IL-4/IL-13-responsive genes
in the spleens of 28-day infected hamsters determined by real time RT-PCR. Data are shown as the mean and standard error of the mean (error
bars) of the fold-increase in infected compared to uninfected animals (n = 5 per group). ***p ≤ 0.001.
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macrophages. The increased expression of arginase 1, CC
chemokine ligand 17 (Ccl17), Ccl22, and Ccl11 was con-
firmed by real time RT-PCR (Figure 4B). An M2b-like
phenotype of macrophages (which demonstrated in-
creased expression of arg1, Mrc1, Clec7a, CCL17, and
IL-10) was also reported in mice infected with L. infan-
tum, a closely related visceralizing species [62].
Conclusions
First generation microarray analysis of gene expression
in the spleens of hamsters with progressive VL demon-
strated a large number of highly upregulated genes.
While the microarray provided only partial coverage of
the hamster transcriptome, transcripts that were part of
the IFN-γ and IL-4/IL-13 signaling pathways were prom-
inently expressed. A robust and functional IFN-γ re-
sponse is clearly evident by the expression of multiple
downstream target genes, but this response does not re-
strain parasite replication. This finding supports the ac-
cumulating evidence that macrophages are ineffectively
activated to kill the parasite in the spleens of progressive
VL. The concomitant expression of IL-4/IL-13 and IL-
10, with the increased expression of genes characteristicof M2 macrophage activation, are likely to contribute to
this. The fundamental mechanism(s) through which the
high level of IFN-γ expression is unable to suppress type
2 cytokine response and mediate classical macrophage
activation remains a mystery. Further dissection of the
regulatory mechanisms that lead to polarization of
macrophages toward a permissive state is needed to fully
understand the pathogenesis of VL.
Methods
Parasites
Leishmania donovani (MHOM/SD/001S-2D) promasti-
gotes were cultured as described previously [63]. Ham-
sters were infected by intracardial injection of 106
peanut agglutinin purified metacyclic promastigotes [63].
Animals
Outbred Syrian hamsters were used for isolation of total
RNA to construct a cDNA library. For gene expression
studies, randomly selected, age-matched female inbred
Chester Beatty hamsters were either uninfected or in-
fected with 1 × 106 metacyclic Leishmania donovani
promastigotes by intracardial injection. Animals (n = 5
per uninfected and infected groups) were sacrificed at 7,
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and frozen at −80°C in RNAlater (Ambion) until the RNA
was isolated. Animals used in this study were handled
according to local and federal regulations. The research
protocols were approved by our Institutional Animal Care
and Use Committee (Protocols 04051-41-05 at UTHSCSA
and 1101004 at UTMB). The ARRIVE Guidelines [64] for
reporting animal research were followed.
Isolation of RNA for the hamster cDNA library
Multiple different hamster cell populations and tissues
were exposed or not to several different noninfectious or
infectious stimuli. Hamster cell and tissue sources of
mRNA used in the construction of the cDNA library in-
cluded: spleen cells: no stimulus, 100 μg/mL Concanavalin
A, 100 μg/mL LPS; peritoneal macrophages: no stimulus,
100 μg/mL LPS; popliteal lymph node tissue from ham-
sters with cutaneous (foot) Leishmania panamensis infec-
tion; mesenteric lymph node tissue from hamsters with
intestinal Ancylostoma duodenale infection; spleen tissue
from normal animals; spleen tissue from animals with
systemic Leishmania donovani infection; liver tissue from
normal animals; liver tissue from animals with systemic
Leishmania donovani infection; epithelial cells infected
with influenza A virus, SARS-CoV, Andes virus or treated
with hamster interferon-alpha. Total RNA was isolated
using the RNAeasy (Qiagen) kit and pooled for the con-
struction of the cDNA library.
Construction of cDNA library
A subtractive directionally cloned cDNA library was con-
structed and sequenced at the Roy J. Carver Biotechnology
Center, University of Illinois at Urbana-Champaign. The
library was prepared as described by Bonaldo et al. [65]
following method 4 with some modifications. Briefly, the
poly(A) +mRNA was isolated from total RNA using the
Oligotex Direct mRNA kit (Qiagen) and converted to
double-stranded cDNA (dscDNA) using the Superscript®
Double-Stranded cDNA Synthesis Kit and an anchor pri-
mer 5′-AACTGGAAGAATTCGCGGCCGCACCGATTT
TTTTTTTTTTTTTTTV-3″ (V = A,C,G). The dscDNAs
were size selected on a 1% agarose gel (>0.5 kb), ligated to
EcoR1 adaptors (Promega) and digested with NotI (NEB).
The dscDNAs were then directionally cloned into EcoR1-
NotI digested pBluescript II SK + phagemid vector (Strata-
gene). The ligated dscDNAs were transformed into
DH10B™cells (Invitrogen). The total number of white col-
ony forming units (cfu) before amplification was 4 × 106.
Blue colonies (empty vectors) were less than 2%.
Normalization/subtraction of the primary hamster cDNA
library
Purified plasmid DNA from the primary library was con-
verted to single-stranded circles and used as a templatefor PCR amplification using the T7 and T3 priming sites
flanking the cloned cDNA inserts as previously de-
scribed [65]. The purified PCR products, representing
the entire cloned cDNA population, and PCR products
from clones found to be abundant in the primary library
were used as a driver for normalization. Hybridization
between the single-stranded library (50 ng) and the PCR
products (500 ng) was carried out for 44 hours at 30°C.
Unhybridized single-stranded DNA circles were sepa-
rated from hybridized DNA, rendered partially double-
stranded and electroporated into DH10B™ cells to
generate the normalized/substracted library. The total
number of clones was 1.5 × 107 cfu. Background of
empty clones was less 2%.
Sanger sequencing of cDNA inserts
Transformed colonies were picked and plated in 384
well plates in LB containing carbenicillin. Plasmids were
extracted and sequenced on Applied Biosciences 3730xl
sequencers. Base calling with quality score was carried
out using Phred. Vector sequence was detected and
trimmed using Cross-Match. Sequences were considered
high quality with average Phred scores of 20 or above
and a minimum of 200 bp after quality and vector trim-
ming. 5085 raw Expressed sequence tags (EST) were
generated from the library. These ESTs were further as-
sembled into contigs. Sequence data were integrated in a
Hamster ‘Expressed Sequence Tag Information Manage-
ment and Annotation’ (ESTIMA) database [66].
cDNA Oligonucleotide printing, microarray slide
preparation and processing
cDNA microarray slides were printed based on EST/
Contigs of candidate genes provided by the cDNA li-
brary sequence. PCR products for printing were synthe-
sized directly off bacterial culture as template. The DNA
amplicons were resuspended in printing buffer using the
Beckman Biomek FX liquid handling robot. Printing
(spotting) of slides, including slide preparation, and
setting up the software, was done at the W. M. Keck
Center for Comparative and Functional Genomics at the
University of Illinois at Urbana-Champaign. Slides were
printed robotically with a GeneMachines OmniGrid 100
microarray printer.
cDNA synthesis, labeling and hybridization
Total RNA was extracted from spleen tissue from each
uninfected and infected hamster using the RNeasy Midi
kit (Qiagen, Foster City, CA). Each RNA sample was
DNase treated with TURBO DNA-freeTM kit (Ambion®)
and quantified using a NanoDrop Spectrophotometer
(Thermo Scientific). Purification of poly A+ RNA from
total RNA was made using the Oligotex mRNA Midi Kit
(Qiagen, Foster City, CA). PolyA+ RNA samples were
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(cDNA) in the presence of amino allyl dUTP (aa-dUTP,
Sigma-Aldrich, St. Louis, MO) and then chemically
coupling the Cy3 or Cy5 dyes (Amersham-Pharmacia
Biotech, Arlington Heights, IL). Briefly, 2 μg of each poly
A+ RNA was annealed to 2 μl of random hexamer
primers (Invitrogen, Carlsbad, CA, 3 mg/mL,) after de-
naturation at 70°C for 10 min. The synthesis of cDNA
was allowed to proceed at 46°C for 4 hours in the
presence of SuperScript II reverse transcriptase (400U
per reaction; Invitrogen, Carlsbad, CA) and amino allyl-
dNTP mix, in a 2:3 aa-dUTP:dTTP ratio. After RNA
degradation and neutralization, unincorporated nucleo-
tides were removed using QiaQuick PCR purification kit
(Qiagen, Foster City, CA) with substitution of potassium
phosphate buffers for the manufacturer’s wash and elu-
tion buffers, which contain free amines that may com-
pete with the Cy dye coupling reaction. cDNA from
each infected hamster was labeled with Cy3 and cDNA
from each uninfected hamster labeled with Cy5 for
1 hour at room temperature in the dark. Unincorporated
dyes were removed using QiaQuick PCR purification kit
(Qiagen, Foster City, CA). Cy3- and Cy5- dye labeled
probes (200 pmoles each) were combined and dried to
completion. In general, labeled cDNA from 1 infected
and 1 uninfected hamster were hybridized simultan-
eously onto a single microarray slide. In addition, one
dye swap was made from each time point using pooled
poly A+ RNA form each group so that each time point
included a total of 6 microarray slides: 5 slides to which
unique uninfected and infected samples were hybridized
and 1 dye swap from pooled poly A+ RNA. Prior to
hybridization, slides were rehydrated with warm 1X SSC
buffer and snap dried for 5 seconds onto a preheated
heat block at 110°C. To couple the DNA spots, slides
were UV cross linked at 120 mJ and incubated in pre-
hybridization buffer (5X SSC, 0.1% SDS and 1% BSA) at
room temperature for 20 min followed by an additional
incubation in pre-warm pre-hybridization buffer in a
42°C water bath for 45 minutes. Slides were washed with
water, dipped in isopropanol and dried by centrifugation
at 550 rpm for 5 minutes. Slides were hybridized within
1 hour of post-processing. Dry Cy3/Cy5 probe mixtures
were resuspended in 24 μL of 1X hybridization buffer
(50% formamide, 5X SSC and 0.1% SDS). To block
nonspecific hybridization 20 μg of Mouse COT-1
DNA® (Invitrogen, Carlsbad, CA) and 20 μg of Poly
(A)-DNA (Amersham-Pharmacia Biotech, Arlington
Heights, IL) were added to each hybridization mixture.
Post-processing slides were hybridized overnight at 42°C
using hybridization chambers (Corning Costar, Acton,
MA). After the hybridization step, slides were washed for
4 min at 42°C in low stringency buffer (1X SSC and 0.2%
SDS), followed by two 2 min wash in a higher stringencybuffer (0.1X SSC and 0.2% SDS) at room temperature,
then by four 4 min wash in the highest stringency buffer
(0.1X SSC) at room temperature and then dried by centri-
fugation at 550 rpm for 5 min. Hybridized slides were
scanned at 635 nm and 532 nm on an Axon 4000 scanner
(Axon Instruments, Foster City, Calif.). A more detailed
protocol is available under request.
Microarray data processing and analysis
Microarray slide data were quantified and .GPR files were
created by using GenePix Pro version 3.0 software. Further
analysis utilized Partek Genomics Suit (Partek GS), version
6.6, 2012 Partek Inc., St. Louis, MO, USA. Briefly, the
GenePix .GPR files were imported into Partek GS, under
the two-color microarray option. Channel 1 was assigned
to the mean feature pixel intensity at 532 nm with the
median background subtracted (F532 Mean - B532) and
channel 2 was assigned to the mean feature pixel intensity
at 635 nm with the median background subtracted (F635
Mean - 635). In general, data were imported only from
un-flagged features and for gene IDs that appeared more
than once in a file the mean was calculated and imported.
The normalization step was performed using total inten-
sity normalization and a log2 transformation to represent
gene expression levels (for a review, see [67]). Each time
point was analyzed separately and files within each time
point were grouped into the uninfected and infected
categories. Analysis of variance (ANOVA) was per-
formed to generate the lists of genes differentially
expressed between the uninfected and infected groups,
and the batch effect ANOVA function of Partek was run
to remove the effect of the dyes from the results. EST
sets with a fold-change >2.0 or < −2 and adjusted p-value
FDR <0.05 [68] were considered differentially expressed
between the uninfected and infected groups.
Gene symbol assignment
Column IDs from the lists of differentially expressed EST
were loaded into the Hamster ESTIMA database to assign
gene symbols of the orthologs of the closest match. When
an ortholog gene symbol could not be assigned through-
out the ESTIMA data base, the trimmed sequence of the
unknown EST was compared to the nucleotide collection
(nr/nt) using the following BLAST programs: Megablast,
for comparing a query to closely related sequences, and
Discontiguous megablast, for cross-species comparisons.
Lists were manually curated to remove non-mammalian,
short sequences, and sequences with no significant align-
ment to the to the nucleotide collection.
Pathway analysis
The lists of differentially expressed genes generated by the
microarray analysis were further analyzed using WebGes-
talt (http://bioinfo.vanderbilt.edu/webgestalt/; last updated
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wikipathways.org) [35] to identify signaling pathways sig-
nificantly overrepresented in the infected spleen tissue.
Quantitative RT-PCR
Total RNA was extracted from 20 μg of spleen tissue from
uninfected hamsters or 28-day infected animals using the
RNeasy kit (QIAGEN). All RNA samples were DNase
treated with TURBO DNA-freeTM kit (Ambion®) and
quantified using a NanoDrop Spectrophotometer (Thermo
Scientific) and maintained at −80°C until ready to use. 250-
500 ng of RNA was used for cDNA synthesis using the high
capacity cDNA reverse transcription kit (Applied Biosys-
tems). Gene expression was determined by SYBR green
(Applied Biosystems) PCR using the following primers
at a final concentration of 300–500 nM: CCL17: For–
GTGCTGCCTGGAGATCTTCA, Rev–TGGCATCCCT
















18 s: For–ACCGCAGCTAGGAATAATGGA, Rev- GCC
TCAGTTCCGAAAACCA. With the exception of CCL17
and IRG1 primers were designed to span an intron, and
were confirmed by efficiency testing and analysis of dis-
sociation curves to not generate primer dimers. Data was
analyzed using the comparative Ct method, relative to
uninfected control spleen, and with the 18S rRNA gene
as the normalizer.
Statistical analysis
Statistical analysis of the microarray data is described
above. Differences in mRNA expression determined by
qRT-PCR between non-infected and the 28-day infected
animals were analyzed by two tail Man-Whitney test or
two tail unpaired t-test using GraphPad Prism version 5.01
for Windows, GraphPad Software, San Diego California
USA (www.graphpad.com).
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